Correlation Between Better Therapeutics and Coya Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Better Therapeutics and Coya Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Better Therapeutics and Coya Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Better Therapeutics and Coya Therapeutics, Common, you can compare the effects of market volatilities on Better Therapeutics and Coya Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Better Therapeutics with a short position of Coya Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Better Therapeutics and Coya Therapeutics,.
Diversification Opportunities for Better Therapeutics and Coya Therapeutics,
-0.57 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Better and Coya is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Better Therapeutics and Coya Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coya Therapeutics, Common and Better Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Better Therapeutics are associated (or correlated) with Coya Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coya Therapeutics, Common has no effect on the direction of Better Therapeutics i.e., Better Therapeutics and Coya Therapeutics, go up and down completely randomly.
Pair Corralation between Better Therapeutics and Coya Therapeutics,
Given the investment horizon of 90 days Better Therapeutics is expected to under-perform the Coya Therapeutics,. In addition to that, Better Therapeutics is 1.49 times more volatile than Coya Therapeutics, Common. It trades about -0.03 of its total potential returns per unit of risk. Coya Therapeutics, Common is currently generating about 0.03 per unit of volatility. If you would invest 457.00 in Coya Therapeutics, Common on September 14, 2024 and sell it today you would earn a total of 117.00 from holding Coya Therapeutics, Common or generate 25.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 29.21% |
| Values | Daily Returns |
Better Therapeutics vs. Coya Therapeutics, Common
Performance |
| Timeline |
| Better Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Coya Therapeutics, Common |
Better Therapeutics and Coya Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Better Therapeutics and Coya Therapeutics,
The main advantage of trading using opposite Better Therapeutics and Coya Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Better Therapeutics position performs unexpectedly, Coya Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coya Therapeutics, will offset losses from the drop in Coya Therapeutics,'s long position.| Better Therapeutics vs. ABVC Biopharma | Better Therapeutics vs. Indaptus Therapeutics | Better Therapeutics vs. Pasithea Therapeutics Corp | Better Therapeutics vs. Forte Biosciences |
| Coya Therapeutics, vs. Cue Biopharma | Coya Therapeutics, vs. Lantern Pharma | Coya Therapeutics, vs. Fennec Pharmaceuticals | Coya Therapeutics, vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |